COMMUNIQUÉS West-GlobeNewswire

Nabriva Therapeutics to Present at the Needham and Company 17th Annual Healthcare Conference
14/03/2018
DUBLIN, Ireland and KING OF PRUSSIA, Pa., March 14, 2018 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV ), a clinical stage biopharmaceutical company engaged in the research and development of novel anti- [...]
BioDelivery Sciences to Present at the Oppenheimer 28th Annual Healthcare Conference
14/03/2018
RALEIGH, N.C., March 14, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI ), a specialty pharmaceutical company with a focus in pain management and addiction medicine, today announced that [...]
Summit Highlights Scientific Rigour of its PhaseOut DMD Clinical Trial at MDA Clinical Conference
14/03/2018
OXFORD, United Kingdom and CAMBRIDGE, Mass., March 14, 2018 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ: SMMT ) (AIM:SUMM) highlighted the rigour being utilised in the collection and analysis of muscle biopsies [...]
Clearside Biomedical Announces Fourth Quarter 2017 Financial Results and Provides Corporate Update
14/03/2018
ALPHARETTA, Ga., March 14, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ: CLSD ), a late-stage clinical biopharmaceutical company developing first-in-class drug therapies to treat back-of-the-eye diseases [...]
Cesca’s Device Subsidiary, ThermoGenesis, Expands into CAR-T Related Contract Development and Manufacturing (CDMO) Services
14/03/2018
RANCHO CORDOVA, Calif., March 14, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca”) (NASDAQ: KOOL ), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today [...]
Olainfarm will hold Fourth Quarter 2017 Investor Conference Webinar
14/03/2018
Olaine, 2018-03-14 11:10 CET (GLOBE NEWSWIRE) -- Webinar will be hosted by the Member of the Management Board Salvis Lapiņš. The presentation will be held in English. During the webinar Salvis Lapiņš will inform about [...]
Curetis Receives USPTO Notice of Allowance for Key Patent Covering Unyvero Technology
14/03/2018
Curetis Receives USPTO Notice of Allowance for Key Patent Covering Unyvero Technology IP position strengthened in the U.S. Patent supports utility of Unyvero Lysator Technology for sample preparation Amsterdam, the [...]
Bio-on launches U-COAT, a company operating in the fertilisers market with a biodegradable controlled-release solution.
14/03/2018
The new company, U-COAT S.p.A. , will sell an innovative solution for the controlled release of Urea fertilisers into the soil. The innovation was developed by Bio-on with PHAs bioplastics, so it is 100% natural and [...]
Kiadis Pharma to Present at the Cowen and Company 38th Annual Health Care Conference
14/03/2018
Kiadis Pharma to Present at the Cowen and Company 38th Annual Health Care Conference Amsterdam, The Netherlands, March 14, 2018 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and Brussels: [...]
DBV Technologies Reports Full Year 2017 Financial Results
14/03/2018
Montrouge, France, March 14, 2018 DBV Technologies Reports Full Year 2017 Financial Results DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT) today announced full year 2017 results. Audit [...]
Résultats Financiers 2017 de DBV Technologies
14/03/2018
Montrouge, France, le 14 mars 2018 (7h30 CET) Résultats Financiers 2017 de DBV Technologies DBV Technologies (Euronext : DBV - ISIN : FR0010417345 - NASDAQ : DBVT), société biopharmaceutique française, a annoncé aujourd [...]
Conditions financières améliorées de l'accord entre Nicox et Bausch + Lomb pour VYZULTA
14/03/2018
Communiqué de presse Conditions financières améliorées de l'accord entre Nicox et Bausch + Lomb pour VYZULTA TM Augmentation des redevances de 1% sur les ventes annuelles mondiales de VYZULTA TM dépassant 300 millions [...]
Nicox Announces Improved Financial Terms from Bausch + Lomb for VYZULTA
14/03/2018
Press Release Nicox Announces Improved Financial Terms from Bausch + Lomb for VYZULTA TM Increase in Royalties by 1% on Annual VYZULTA TM Global Sales Revenue Over $300 Million Additional $20 Million in Potential [...]
2017: Tecan with significant increase in sales and profit
14/03/2018
Financial results: full-year and second half of 2017 Order entry of CHF 564.1 million (2016: CHF 503.2 million) Full-year growth of 11.8% in local currencies or 12.1% in Swiss francs Double-digit growth rates in both [...]
Immuron Announces A$5.1M Private Placement to U.S. Fund
13/03/2018
MELBOURNE, Australia, March 13, 2018 (GLOBE NEWSWIRE) -- Immuron Limited (ASX:IMC) (NASDAQ: IMRN ), an Australian microbiome biopharmaceutical company focused on developing and commercializing orally delivered targeted [...]
BioStem Technologies Inc. Announces Engagement of Dr. Felix Amon for Pharmaceutical Business Development
13/03/2018
Pompano Beach, FL, March 13, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM) (“BioStem” or the “Company”), a global life sciences corporation, providing innovative technologies with a focus in [...]
CORRECTING and REPLACING -- Intercept to Present at Upcoming Conference
13/03/2018
NEW YORK, March 13, 2018 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT ) please note that the conference date should be March 20, not [...]
Antares Pharma Provides Update Regarding the Cowen and Company 38th Annual Healthcare Conference
13/03/2018
EWING, N.J., March 13, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS ) (the Company) today announced that due to the blizzard conditions and lack of travel options present in the greater Boston area, the [...]
Xeris Pharmaceuticals Announces a Formulation Development Collaboration with Asahi Kasei Pharma
13/03/2018
Chicago, March 13, 2018 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. (“Xeris”), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and [...]

Pages